MedBen Rx
  • About Us
  • Genomic Testing
  • Resources
    • MedBen Rx Blog
    • Online Services & Forms
  • Contact Us
  • MedBen Access
  • MedBen.com
Select Page

Save 10-40% on Rx Costs by Using the Most Effective Drugs

Nov 12, 2021 | Comparative Effectiveness, Evidence-based research, Generic Drugs, MedBen Rx, Prescription drugs, Rx Costs, Rx Spending, Savings, Specialty Drugs

MedBen Rx comparative effectiveness brings clinical research and employers together to find the most effective drugs at the best cost. You can save 10-40% on pharmacy costs by changing to drugs with better outcomes. The benefits of comparative effectiveness include:...

Rx Comparative Effectiveness – Contact Us for Your Free, No-Obligation Analysis

Oct 6, 2021 | Comparative Effectiveness, MedBen Rx, Prescription drugs, Rx Costs, Rx Spending, Savings

By using comparative effectiveness to deliver the best drug outcomes, MedBen Rx clients save on pharmacy costs. Would you like to find out how much you could save? MedBen Rx offers a no-cost, no-obligation analysis of the savings potential from adding comparative...

Are Generics Always Your Best Rx Value?

Aug 9, 2021 | Comparative Effectiveness, Generic Drugs, MedBen Rx, Prescription drugs, Rx Costs, Rx Spending, Savings

Generic doesn’t always mean cheap. As this list recently compiled by GoodRx demonstrates, the monthly cost of some popular generic drugs can actually rival or exceed well-known brand medications. MedBen Rx comparative effectiveness ensures that members are using the...

MedBen Rx Solutions Help Fight Drug Price Hikes

Jun 14, 2021 | Brand Name Drugs, Comparative Effectiveness, MedBen Rx, Prescription drugs, Rx Costs, Savings, Specialty Drugs

The prices of 260 popular brand-name prescription drugs rose 3% from 2019 to 2020 – twice as much as the 1.3% rate of inflation during the same period, according to a new AARP report. Their analysis also found that over the past 15 years, prices of 65 common brands...

Rx Plans Focusing on Best Outcomes Also Deliver Healthier Bottom Line

May 17, 2021 | Comparative Effectiveness, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription drugs, Savings

MedBen Rx clients can save between 10-30% by using comparative effectiveness focusing on the best drug outcomes. One way it does this is by dispelling the costly misperception that “new is better.” “A new FDA approved drug doesn’t mean it’s better than existing...

New MedBen Rx Program Reduced Client Diabetic Drug Spend by 77%

Apr 6, 2021 | Case Study, Comparative Effectiveness, Diabetes, MedBen Rx

MedBen Rx Comparative Effectiveness uses evidence-based research to make sure your members are taking the most effective drugs at the best cost. A MedBen Rx client recently changed their formulary by using Comparative Effectiveness to focus on drugs that would produce...
Next Entries »

Categories

  • 340B
  • Access solution
  • Access solutions
  • Acquisition Cost Index (ACI)
  • Affordable Care Act
  • Anniversaries
  • Announcements
  • Appropriateness Solutions
  • Avande
  • Average Wholesale Price
  • Benefits Advisory Conference
  • Benefits preservation
  • Biologics
  • Biosimilar
  • Brand Name Drugs
  • Brian Fargus
  • Cancer
  • Caroline Fraker
  • Case Study
  • Cholesterol
  • Claims
  • Client Report
  • Comparative Effectiveness
  • Compliance
  • Consolidated Appropriations Act of 2021 (CAA)
  • Cost Plus
  • Cost Plus Pricing
  • Cost projections
  • Cost Savings
  • Diabetes
  • Discounts
  • Doug Freeman
  • Drug costs
  • Drug makers
  • Drug marketing
  • Drug reimportation
  • Evidence-based research
  • Federal Trade Commission (FTC)
  • Food and Drug Administration (FDA)
  • Formularies
  • Fraud
  • Gene therapy
  • Generic Drugs
  • Genetic testing
  • Genomics
  • GLP-1s
  • Government
  • Guarantees
  • Health and Human Services
  • Health systems
  • Heart medications
  • High-value formulary
  • History
  • Humalog
  • Humira
  • Idacio
  • Inflation
  • Kurt Harden
  • Lawsuits
  • Legislation
  • Limited Use HRA
  • Lobbying
  • Luke Burchard
  • MDMA (ecstasy)
  • MedBen
  • MedBen Access
  • MedBen Basics
  • MedBen Board of Directors\
  • MedBen employees
  • MedBen Rx
  • MedBen Rx Advocate
  • MedBen Rx Alliance
  • MedBen Rx News
  • MedBen University
  • Medicare
  • Mobile app
  • Mounjaro
  • News
  • Nutrigenomics
  • Online Services
  • Opinions
  • Outcomes
  • Overprescribing
  • Own Use
  • Ozempic
  • Patient advocacy program
  • Perigon Pharmacy 360
  • Pharmacies
  • Pharmacogenomics
  • Pharmacy Benefits Manager (PBM)
  • Pharmacy Services Administrator (PSA)
  • Precision medicine
  • Prescription drugs
  • Prescription Portal
  • Pricing solutions
  • Psychedelic drugs
  • Rebates
  • Regulatory
  • Reporting
  • Research
  • Rx Advertising
  • Rx Costs
  • Rx Facts
  • Rx prices
  • Rx Spending
  • RxDC report
  • Savings
  • Specialty Drugs
  • Spread Pricing
  • State legislation
  • Statins
  • Stelara
  • Study
  • Surveys
  • Transparency
  • Trend
  • TruDataRx
  • Trulicity
  • Value
  • Ventegra
  • Wegovy
  • Weight loss
  • Weight loss drugs
  • Weight management
  • Wellness
  • White paper
  • Zepbound
  • About Us
  • Contact Us
  • Blog
  • Online Services
  • MedBen Access
  • Sitemap
  • Privacy
  • MedBen.com

Sign Up for our Newsletter

  • This field is for validation purposes and should be left unchanged.
© 2025 MedBen Rx. All rights reserved.